Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use- Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma ...
Abstract
Authors
F Taylor H Dastani B Bennett M DeRosa E Berghorn D Justin